Brokerages Set CVS Health Co. (NYSE:CVS) Price Target at $70.33

CVS Health Co. (NYSE:CVS - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twenty brokerages that are currently covering the company, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $70.33.

Several equities research analysts have recently commented on CVS shares. Mizuho reduced their price target on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a research report on Thursday, October 24th. Truist Financial reaffirmed a "buy" rating and set a $67.00 target price (down from $76.00) on shares of CVS Health in a report on Wednesday, November 20th. Cantor Fitzgerald reiterated a "neutral" rating and set a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. UBS Group upped their price objective on CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a research note on Thursday, November 7th. Finally, Wells Fargo & Company upgraded CVS Health from an "equal weight" rating to an "overweight" rating and lifted their target price for the company from $60.00 to $66.00 in a research report on Monday, November 18th.

Institutional Trading of CVS Health

A number of hedge funds have recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health in the 3rd quarter worth approximately $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the third quarter worth $31,000. Legacy Investment Solutions LLC acquired a new stake in shares of CVS Health in the 3rd quarter worth $31,000. Reston Wealth Management LLC purchased a new position in CVS Health during the 3rd quarter worth $32,000. Finally, First Community Trust NA increased its position in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock valued at $33,000 after buying an additional 302 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Stock Down 0.2 %

Shares of CVS traded down $0.11 on Friday, hitting $59.85. 3,947,743 shares of the stock traded hands, compared to its average volume of 11,314,412. The company has a market capitalization of $75.32 billion, a PE ratio of 15.19, a P/E/G ratio of 1.02 and a beta of 0.55. CVS Health has a one year low of $52.71 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The business has a 50 day simple moving average of $59.36 and a 200 day simple moving average of $58.75.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business had revenue of $95.43 billion for the quarter, compared to analysts' expectations of $92.72 billion. During the same quarter in the prior year, the business earned $2.21 EPS. The business's revenue for the quarter was up 6.3% compared to the same quarter last year. As a group, equities analysts forecast that CVS Health will post 5.37 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.44%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health's dividend payout ratio (DPR) is presently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.